EdgarLookup

WORLD ACCEPTANCE CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that WORLD ACCEPTANCE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
26.8%
Profit Margin
Net income ÷ revenue
4.4%
Return on Assets
Net income ÷ assets
1.29x
Debt-to-Equity
Total liabilities ÷ equity
+19.2%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $165.27M May 22, 2025
FY2025 Dec 31, 2024 $138.63M May 22, 2025
FY2025 Sep 30, 2024 $131.41M May 22, 2025
FY2025 Jun 30, 2024 $129.53M May 22, 2025
FY2025 Mar 31, 2024 $159.27M May 22, 2025
FY2025 Dec 31, 2023 $137.75M May 22, 2025
FY2025 Sep 30, 2023 $136.88M May 22, 2025
FY2025 Jun 30, 2023 $139.32M May 22, 2025
FY2024 Mar 31, 2023 $160.84M May 23, 2024
FY2024 Dec 31, 2022 $146.53M May 23, 2024

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $44.28M May 22, 2025
FY2025 Dec 31, 2024 $13.39M May 22, 2025
FY2025 Sep 30, 2024 $22.13M May 22, 2025
FY2025 Jun 30, 2024 $9.95M May 22, 2025
FY2025 Mar 31, 2024 $35.06M May 22, 2025
FY2025 Dec 31, 2023 $16.67M May 22, 2025
FY2025 Sep 30, 2023 $16.08M May 22, 2025
FY2025 Jun 30, 2023 $9.54M May 22, 2025
FY2024 Mar 31, 2023 $24.63M May 23, 2024
FY2024 Dec 31, 2022 $5.81M May 23, 2024

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $254.16M May 22, 2025
FY2025 Mar 31, 2024 $265.78M May 22, 2025
FY2025 Mar 31, 2023 $291.55M May 22, 2025
FY2024 Mar 31, 2022 $272.45M May 23, 2024
FY2023 Mar 31, 2021 $226.95M Jun 1, 2023
FY2022 Mar 31, 2020 $280.98M May 27, 2022
FY2021 Mar 31, 2019 $244.66M Jun 2, 2021
FY2019 Mar 31, 2018 $218.03M May 29, 2020
FY2018 Mar 31, 2017 $219.36M May 24, 2019
FY2017 Mar 31, 2016 $206.07M Jun 13, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $3.68M May 22, 2025
FY2025 Mar 31, 2024 $5.93M May 22, 2025
FY2025 Mar 31, 2023 $5.83M May 22, 2025
FY2024 Mar 31, 2022 $6.07M May 23, 2024
FY2023 Mar 31, 2021 $11.68M Jun 1, 2023
FY2022 Mar 31, 2020 $11.28M May 27, 2022
FY2021 Mar 31, 2019 $9.81M Jun 2, 2021
FY2019 Mar 31, 2018 $9.17M May 29, 2020
FY2018 Mar 31, 2017 $6.81M May 24, 2019
FY2017 Mar 31, 2016 $8.65M Jun 13, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $1.01B May 22, 2025
FY2025 Mar 31, 2024 $1.06B May 22, 2025
FY2024 Mar 31, 2023 $1.12B May 23, 2024
FY2023 Mar 31, 2022 $1.22B Jun 1, 2023
FY2022 Mar 31, 2021 $954.27M May 27, 2022
FY2021 Mar 31, 2020 $1.03B Jun 2, 2021
FY2019 Mar 31, 2019 $854.99M May 29, 2020
FY2018 Mar 31, 2018 $840.99M May 24, 2019
FY2017 Mar 31, 2017 $800.59M Jun 13, 2018
FY2016 Mar 31, 2016 $806.22M Jun 29, 2017

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $568.15M May 22, 2025
FY2025 Mar 31, 2024 $631.92M May 22, 2025
FY2024 Mar 31, 2023 $732.09M May 23, 2024
FY2023 Mar 31, 2022 $845.27M Jun 1, 2023
FY2022 Mar 31, 2021 $549.34M May 27, 2022
FY2021 Mar 31, 2020 $618.12M Jun 2, 2021
FY2019 Mar 31, 2019 $302.87M May 29, 2020
FY2018 Mar 31, 2018 $299.88M May 24, 2019
FY2017 Mar 31, 2017 $339.53M Jun 13, 2018
FY2016 Mar 31, 2016 $414.32M Jun 29, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $439.48M May 22, 2025
FY2025 Mar 31, 2024 $424.43M May 22, 2025
FY2025 Mar 31, 2023 $385.23M May 22, 2025
FY2025 Mar 31, 2022 $373.02M May 22, 2025
FY2024 Mar 31, 2021 $404.93M May 23, 2024
FY2023 Mar 31, 2020 $411.96M Jun 1, 2023
FY2022 Mar 31, 2019 $552.12M May 27, 2022
FY2021 Mar 31, 2018 $541.11M Jun 2, 2021
FY2019 Mar 31, 2017 $461.06M May 29, 2020
FY2018 Mar 31, 2016 $391.90M May 24, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $7.37M May 22, 2025
FY2025 Mar 31, 2024 $7.37M May 22, 2025
FY2024 Mar 31, 2023 $7.37M May 23, 2024
FY2023 Mar 31, 2022 $7.37M Jun 1, 2023
FY2022 Mar 31, 2021 $7.37M May 27, 2022
FY2022 Mar 31, 2020 $7.37M May 27, 2022
FY2021 Mar 31, 2019 $7.03M Jun 2, 2021
FY2019 Mar 31, 2018 $7.03M May 29, 2020
FY2018 Mar 31, 2017 $6.07M May 24, 2019
FY2017 Mar 31, 2016 $6.12M Jun 13, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $173.05M May 22, 2025
FY2025 Mar 31, 2024 $137.99M May 22, 2025
FY2024 Mar 31, 2023 $97.15M May 23, 2024
FY2023 Mar 31, 2022 $92.12M Jun 1, 2023
FY2022 Mar 31, 2021 $149.34M May 27, 2022
FY2021 Mar 31, 2020 $184.75M Jun 2, 2021
FY2019 Mar 31, 2019 $353.99M May 29, 2020
FY2018 Mar 31, 2018 $391.28M May 24, 2019
FY2017 Mar 31, 2017 $344.61M Jun 13, 2018
FY2016 Mar 31, 2016 $276.00M Jun 29, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $9.73M May 22, 2025
FY2025 Mar 31, 2024 $11.84M May 22, 2025
FY2024 Mar 31, 2023 $16.51M May 23, 2024
FY2023 Mar 31, 2022 $19.24M Jun 1, 2023
FY2022 Mar 31, 2021 $15.75M May 27, 2022
FY2021 Mar 31, 2020 $11.62M Jun 2, 2021
FY2019 Mar 31, 2019 $9.34M May 29, 2020
FY2019 Mar 31, 2018 $12.47M May 29, 2020
FY2019 Mar 31, 2017 $11.58M May 29, 2020
FY2018 Mar 31, 2016 $8.10M May 24, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $447.86M May 22, 2025
FY2024 Mar 31, 2024 $498.42M May 23, 2024
FY2023 Mar 31, 2023 $598.77M Jun 1, 2023
FY2022 Mar 31, 2022 $696.97M May 27, 2022
FY2021 Mar 31, 2021 $405.01M Jun 2, 2021
FY2019 Mar 31, 2020 $451.10M May 29, 2020
FY2018 Mar 31, 2019 $251.94M May 24, 2019
FY2017 Mar 31, 2018 $244.90M Jun 13, 2018
FY2016 Mar 31, 2017 $295.14M Jun 29, 2017
FY2015 Mar 31, 2016 $374.69M Jun 1, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 8 May 22, 2025
FY2025 Dec 31, 2024 2 May 22, 2025
FY2025 Sep 30, 2024 4 May 22, 2025
FY2025 Jun 30, 2024 1 May 22, 2025
FY2025 Mar 31, 2024 6 May 22, 2025
FY2025 Dec 31, 2023 2 May 22, 2025
FY2025 Sep 30, 2023 2 May 22, 2025
FY2025 Jun 30, 2023 1 May 22, 2025
FY2024 Mar 31, 2023 4 May 23, 2024
FY2024 Dec 31, 2022 1 May 23, 2024

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 8 May 22, 2025
FY2025 Dec 31, 2024 2 May 22, 2025
FY2025 Sep 30, 2024 3 May 22, 2025
FY2025 Jun 30, 2024 1 May 22, 2025
FY2025 Mar 31, 2024 6 May 22, 2025
FY2025 Dec 31, 2023 2 May 22, 2025
FY2025 Sep 30, 2023 2 May 22, 2025
FY2025 Jun 30, 2023 1 May 22, 2025
FY2024 Mar 31, 2023 4 May 23, 2024
FY2024 Dec 31, 2022 0 May 23, 2024

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 5.37M May 22, 2025
FY2025 Mar 31, 2024 5.94M May 22, 2025
FY2024 Mar 31, 2023 6.23M May 23, 2024
FY2023 Mar 31, 2022 6.35M Jun 1, 2023
FY2022 Mar 31, 2021 6.81M May 27, 2022
FY2021 Mar 31, 2020 7.81M Jun 2, 2021
FY2019 Mar 31, 2019 9.28M May 29, 2020
FY2018 Mar 31, 2018 9.12M May 24, 2019
FY2017 Mar 31, 2017 8.78M Jun 13, 2018
FY2016 Mar 31, 2016 8.81M Jun 29, 2017